Nov 9 (Reuters) - AGFA Gevaert NV AGFB.BR :
* Q3 ADJUSTED EBITDA 35% HIGHER THAN IN Q3 OF 2020
* Q3 GOOD MARGIN PERFORMANCE VERSUS Q3 2020 DESPITE
INCREASING
INFLATIONARY PRESSURE AND SUPPLY CHAIN ISSUES
* Q3 DECENT TOP LINE RECOVERY BUT CONTRASTED PERFORMANCE
BETWEEN
DIVISIONS
* Q3 STRONG PRICE ACTIONS IN PLACE AS CONTRACTS ALLOW
* Q3 WORKING CAPITAL STABLE ASA PERCENTAGE OF SALES DESPITE
RAW
MATERIAL COST INFLATION AND SUPPLY CHAIN ISSUES
* OUTLOOK 2021 : AGFA-GEVAERT GROUP EXPECTS AN UPTURN IN
PERFORMANCE FOR HEALTHCARE IT DIVISION IN Q4
* GROUP'S EBITDA IS EXPECTED TO BE BELOW LEVEL OF Q4 OF 2020
* IT IS EXPECTED THAT INFLATIONARY PRESSURE AND SUPPLY CHAIN
ISSUES WILL CONTINUE TO HAVE AN IMPACT IN FIRST QUARTERS OF NEXT
YEAR
* Q3 REVENUE EUR 439 MILLION VERSUS EUR 410 MILLION YEAR AGO
* Q3 NET LOSS EUR 5 MILLION VERSUS LOSS OF EUR 25 MILLION
YEAR AGO
* Q3 ADJUSTED EBITDA EUR 21 MILLION VERSUS EUR 16 MILLION
YEAR AGO
* RESTRUCTURING AND NON-RECURRING ITEMS RESULTED IN AN
EXPENSE OF
7 MILLION EURO, VERSUS AN EXPENSE OF 9 MILLION EURO IN Q3 OF
2020
* IT IS EXPECTED THAT INFLATIONARY PRESSURE AND SUPPLY CHAIN
ISSUES WILL CONTINUE TO HAVE AN IMPACT IN FIRST QUARTERS OF NEXT
YEAR
* DUE TO SUCCESSFUL PRICE ACTIONS FOR OUR FILM PRODUCTS,
PRINTING
PLATES, AND STRICT COST MANAGEMENT, OUR MARGINS REMAINED AT
DECENT LEVEL COMPARED TO LAST YEAR - CEO
* Q3 GROSS PROFIT MARGIN REMAINED ALMOST STABLE AT 26.8% OF
REVENUE
Source text for Eikon: ID:nGNE33tmKT
Further company coverage: AGFB.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))